Tag: Advocacy

The last installment in our end-of-year series of expert roundups might be the least flashy, but it is arguably no less important than the previous ones dedicated to longevity biotech and geroscience. Public advocacy is a powerful lever. To quote Abraham Lincoln: “Public sentiment is everything. With it, nothing can fail; against it, nothing can...

Happy holidays! Winter is in full swing for those of us in the Northern Hemisphere. It is a time for cozy nights by the fire and a great time to catch up on what has been happening at Lifespan News and LRI. A cultural intelligence platform for effective advocacy We are delighted to announce that...

The idea of living longer, healthier lives thanks to rejuvenation biotechnology has steadily become more common. Gradually increasing numbers of articles are discussing this idea, especially as science is starting to catch up and may eventually even deliver on it. With that in mind, I was pleasantly surprised this week to be greeted by an...

To challenge cultural stereotypes and misconceptions about longevity, a new organization aims to engage people who create culture. Its list of “cultural ambassadors" includes Oscar- and Grammy-winning artists. Reframing the case for longevity Even as geroscience is becoming a respected field, producing breakthroughs and spawning dozens of startups, the public’s attitudes toward longevity still largely...

For those of us in the Northern Hemisphere, autumn is underway. The fall is a time when the leaves that are green turn to brown, so let us see what the Lifespan team has been working on to help our field keep our own metaphorical leaves green and healthy. Top longevity news stories of Summer...

A paper published in Bioethics makes a startling case for people to die at 100 years old rather than live as long as they might choose. Deathism is relatively rare People who wholeheartedly believe that human lifespans should be restricted to a pre-defined span are not common. Most popular concerns around life extension involve its...